1. Home
  2. GEVO vs BNTC Comparison

GEVO vs BNTC Comparison

Compare GEVO & BNTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gevo Inc.

GEVO

Gevo Inc.

HOLD

Current Price

$2.07

Market Cap

470.1M

Sector

Industrials

ML Signal

HOLD

Logo Benitec Biopharma Inc.

BNTC

Benitec Biopharma Inc.

HOLD

Current Price

$13.09

Market Cap

405.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GEVO
BNTC
Founded
2005
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
470.1M
405.7M
IPO Year
2011
N/A

Fundamental Metrics

Financial Performance
Metric
GEVO
BNTC
Price
$2.07
$13.09
Analyst Decision
Buy
Strong Buy
Analyst Count
2
3
Target Price
$8.13
$27.67
AVG Volume (30 Days)
2.5M
245.8K
Earning Date
11-10-2025
02-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$120,932,000.00
N/A
Revenue This Year
$913.54
N/A
Revenue Next Year
$11.79
N/A
P/E Ratio
N/A
N/A
Revenue Growth
675.75
N/A
52 Week Low
$0.92
$9.70
52 Week High
$2.98
$17.15

Technical Indicators

Market Signals
Indicator
GEVO
BNTC
Relative Strength Index (RSI) 42.55 52.44
Support Level $2.16 $10.99
Resistance Level $2.24 $13.36
Average True Range (ATR) 0.11 0.94
MACD -0.02 0.15
Stochastic Oscillator 3.90 84.69

Price Performance

Historical Comparison
GEVO
BNTC

About GEVO Gevo Inc.

Gevo Inc is a renewable chemicals and biofuels company engaged in the development and commercialization of alternatives to petroleum-based products based on isobutanol produced from renewable feedstocks. The operating segments are the Gevo segment, GevoFuels segment, and the GevoRNG segment. By its segments, it is involved in research and development activities related to the future production of SAF, commercial opportunities for other renewable hydrocarbon products and isobutanol, including the development of its biocatalysts, and the produces-pipeline quality methane gas captured from dairy cow manure. The company derives maximum revenue from the GevoRNG segment.

About BNTC Benitec Biopharma Inc.

Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.

Share on Social Networks: